Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

In other words, a non-painful stimulus – like when you rub your shin after walking into a table – can overtake slower pain ...

Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, focusing on innovative treatments. MISSION VIEJO, CALIFORNIA / ACCESS Newswire / ...

Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, ...

Spinal cord injury (SCI) remains the most serious complication of repairing descending thoracic and thoracoabdominal aortic aneurysms, with endovascular ...

Sylvie Hudon was admitted to the hospital, she says nurses visiting her home told her not to worry about the bedsore located ...

Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...

Castile-La Mancha, Spain - The kings heard this Wednesday stories of patients during their visit to the National Hospital of Paraplegics in Toledo, which has celebrated 50 years as a public reference ...

More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Neuvotion announced today that it received FDA 510(k) clearance for its first product, the NeuStim wearable device.